FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 184 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated, PD-L1-positive, Advanced TNBC FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma MOST POPULAR ESMO Welcomes the European Commission’s Life Sciences Strategy: A Vital Step... July 4, 2025 First targeted treatment approved for advanced prostate cancer on NHS in... October 13, 2021 Sacituzumab Govitecan Demonstrates Significant Improvement in PFS in Heavily Pretreated, Locally... September 5, 2022 Protective HPV Vaccine-Induced Antibody Titres Can Be Detected Up To 12... June 1, 2021 Load more HOT NEWS Educators Raise Money in Memory of Teacher Who Dedicated Herself to... Immunotherapy Combinations for Treating Metastatic Melanoma and Using Technology to Find... ΠΟΝΟΣ The Potential of AI to Improve Cancer Care is Only Going...
